Citadel Advisors
LEXX icon

Citadel Advisors’s Lexaria Bioscience LEXX Stock Holding History

Citadel Advisors’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5K Buy
+13,513
New +$9.81K ﹤0.01% 12750
2024
Q2 		– Sell
-15,856
Closed -$57.6K – 14932
2024
Q1 		$57.6K Sell
15,856
-13,705
-46% -$34.9K ﹤0.01% 12042
2023
Q4 		$37K Buy
+29,561
New +$38.1K ﹤0.01% 12078
2023
Q1 		– Sell
-18,674
Closed -$45.8K – 15140
2022
Q4 		$45.8K Sell
18,674
-6,200
-25% -$14.8K ﹤0.01% 12244
2022
Q3 		$61K Sell
24,874
-3,014
-11% -$8.59K ﹤0.01% 11488
2022
Q2 		$83K Buy
+27,888
New +$74.7K ﹤0.01% 11568
2021
Q2 		– Sell
-14,915
Closed -$84K – 14073
2021
Q1 		$84K Buy
+14,915
New +$87.4K ﹤0.01% 12607

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Citadel Advisors's LEXX Position: Q1 2026 in Review

Citadel Advisors opened a new position in Lexaria Bioscience (LEXX) in Q1 2026: 13,513 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #12750 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in LEXX as recently as Q1 2024.

Citadel Advisors first reported a position in LEXX in Q1 2021 and has held it in 7 quarters since. The position peaked at $84K in Q1 2021. 28 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Citadel Advisors held 13,513 shares of Lexaria Bioscience worth $10.5K as of Q1 2026.
  • Lexaria Bioscience was a new Citadel Advisors position in Q1 2026.
  • Lexaria Bioscience made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12750 holding.
  • Citadel Advisors first reported a position in Lexaria Bioscience in Q1 2021 and has held it in 7 quarters since.
  • Citadel Advisors's Lexaria Bioscience position peaked at $84K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.